0000950170-23-058900.txt : 20231103 0000950170-23-058900.hdr.sgml : 20231103 20231103170406 ACCESSION NUMBER: 0000950170-23-058900 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hopkins Janet Jill CENTRAL INDEX KEY: 0001997710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 231377220 MAIL ADDRESS: STREET 1: C/O AURA BIOSCIENCES, INC. STREET 2: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 4 1 ownership.xml 4 X0508 4 2023-11-01 0001501796 Aura Biosciences, Inc. AURA 0001997710 Hopkins Janet Jill C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235 false true false false Chief Medical Officer false Common Stock 2023-11-01 4 A false 135000 0 A 135000 D Stock Option (Right to Buy) 8.97 2023-11-01 4 A false 200000 0 A 2033-10-31 Common Stock 200000 200000 D These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Company's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Company's common stock. These RSUs vest in four substantially equal annual installments beginning on November 15, 2024, subject to the Reporting Person's continued service as of each such vesting date. The shares underlying this option vest as follows: 25% of the shares vest on October 16, 2024 with the remainder vesting thereafter in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. /s/ Julie Feder, Attorney-in-fact 2023-11-03